Molecular basis of alpha-1-antitrypsin deficiency

The American Journal of Medicine

Volumn 84, Issue SUPPL. 6, 1988, Pages 13-31

  Brantly, Mark ^a   Nukiwa, Toshihiro ^a   Crystal, Ronald G ^a  

^a Division of Prevention and Population Sciences National Heart Lung Blood Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; HEREDITY; HUMAN; SERUM;

ALLELES; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; GENE EXPRESSION REGULATION; HUMAN; LIVER DISEASES; PULMONARY EMPHYSEMA; SUPPORT, NON-U.S. GOV'T;

EID: 0023898432     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(88)80066-4     Document Type: Article

References (212)

1. α1-Antitrypsin deficiency
2. 1-antitrypsin deficiency
3. 1-antitrypsin deficiency
4. Cirrhosis associated with alpha-1-anfitrypsin deficiency: a previously unrecognized inherited disorder
5. α1-Antitrypsin and its deficiency
6. α1-Antitrypsin: structure, variation and disease
7. The electrophoretic α1-globuiin pattern of serum in α1-antitrypsin deficiency
8. Pulmonary emphysema and alpha-1-antitrypsin deficiency
9. Studies in α1-antitrypsin deficiency
10. α1-Antitrypsin aus human serum
11. Human plasma proteinase inhibitors
12. Kinetics of association of serine proteinases with native and oxidized α-1-Proteinase inhibitor and α-1-antichymotrypsin
13. Human α1-preteinase inhibitor
14. Structure and variation of human α1-antitrypsin
15. Human α1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function
16. The Pi polymorphism: genetic, biochemical, and clinical aspects of human α1-antitrypsin
17. Report of nomenclature meeting for α1-antitrypsin: INSERM, Rouen/Bois-Guillaume, 1978
18. Studies on the oligosaccharide chains of human α1-protease inhibitor: I. Isolation of glycopeptides
19. Studies on the oligosaccharide chains of human α1-protease inhibitor: II. Structure of oligosaccharides
20. Human α1-antitrypsin: carbohydrate attachment and sequence homology
21. α1-Antitrypsin microheterogeneity: isolation and physiological significance of isoforms
22. Isolation and characterization of two minor fractions of α1-antitrypsin by high-performance liquid chromatographic chromatofocusing
23. Elastases: catalytic and biological properties
24. Studies on reactivity of human leukocyte elastase, cathepsin G, and porcine pancreatic elastase toward peptides including sequences related to the reactive site of α1-protease inhibitor (α1-antitrypsin)
25. X-ray crystal structure of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor
26. Human alpha-1-protease inhibitor mechanism of action: evidence for activation by limited proteolysis
27. Z-type α1-antitrypsin is less competent then M1-type α1-antitrypsin as an inhibitor of neutrophil elastase
28. Evaluation of the S-type of α1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase
29. 1-antitrypsin deficiency associated with emphysema
30. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy
31. Metabolism of intact and desialylated α1-antitrypsin
32. malton and of asialylated M-protein in man
33. Metabolism of immunoglobulins
34. Complete sequence of the cDNA for human α1-antitrypsin and the gene for the S variant
35. Regional location of α1-antichymotrypsin and α1-antitrypsin genes on human chromosome 14
36. The human α1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes
37. Molecular analysis of the serine proteinase inhibitor gene family
38. Species- and tissue-specific expression of human α1-antitrypsin in transgenic mice
39. Synthesis of the plasma proteins
40. Expression of the α1-proteinase inhibitor gene in human monocytes and macrophages
41. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals
42. Genetically determined differences in the response of alpha-1-antitrypsin levels in human serum to typhoid vaccine
43. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins
44. Sequential changes of plasma proteins after surgical trauma
45. The effect of tamoxifen in intermediate alpha-1-antitrypsin deficiency associated with the phenotype PiSZ
46. Danazol-induced augmentation of serum α1-antitrypsin levels in individuals with marked deficiency of this antiprotease
47. Evaluation of tamoxifen as a therapy to augment alpha-1-antitrypsin concentrations in Z homozygous alpha-1-antitrypsin-deficient individuals
48. Elastase regulates synthesis of its inhibitor, α1-proteinase inhibitor (A1PI), and exaggerates the defect in A1PI deficiency
49. Cell-specific expression of a transfected human α1-antitrypsin gene
50. Cis- and transacting elements responsible for the cell-specific expression of the human α1-antitrypsin gene
51. The isolation of a clone of α1-antitrypsin and the detection of α1-antitrypsin in mRNA from liver and leukocytes
52. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice
53. Topography of glycosylation in the rough endoplasmic reticulum and golgi apparatus
54. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains
55. Biosynthetic protein transport and sorting by the endoplasmic reticulum and golgi
56. Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the golgi complex
57. Electrophoretic microheterogeneity of serum α1-antitrypsin
58. A new method for determination of alpha-1-antitrypsin phenotypes using isoelectric focusing on polyacrylamide gel slabs
59. α1-Antitrypsin: common subtypes of piM
60. α1-Antitrypsin M1: a new common genetically determined variant
61. Molecular basis for the α1-protease inhibitor deficiency
62. Molecular abnormality of human alpha-1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency
63. Amino acid substitution Gly→Lys in α1-antitrypsin piZ
64. Properties of isolated human α1-antitrypsins of Pi types M, S and Z
65. α1-Antitrypsin: structural relationships of the substitutions of the S and Z variants
66. Inherited differences in alpha-1-antitrypsin
67. The Pi system-inherited variants of serum α1-antitrypsin
68. Quantitative studies on the inherited variants of serum α1-antitrypsin
69. The polymorphism of “prealbumins” and α1-antitrypsin in human sera
70. Characterization of the M1(Ala213) type of α1-antitrypsin a newly recognized common “normal” α1-antitrypsin haplotype
71. granite falls, a nonexpressing α1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon
72. Emphysema associated with complete absence of α1-antitrypsin in serum and the homozygous inheritance of stop codon in α1-antitrypsin coding exon
73. heerlen
74. Identification and molecular analysis of a new variant of α1-antitrypsin characterized by marked reduction of serum levels
75. A null allele of the human α1-antitrypsin gene is caused by a frame-shift mutation
76. Proteolytic cleavages in α1-antitrypsin and microheterogeneity
77. Improved resolution of Pi (α1-antitrypsin) phenotypes by a large-scale immobilized pH gradient
78. α1-Antitrypsin deficiency detection by direct analysis of the mutation in the gene
79. Evaluation of “at risk” alpha-1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes
80. DNA restriction fragments associated with α1-antitrypsin indicate a single origin for deficiency allele Pi Z
81. Mutation and polymorphism of the human β-globin gene and its surrounding DNA
82. Disease diagnosis by recombinant DNA methods
83. Prenatal diagnosis of α1-antitrypsin deficiency by direct analysis of the mutation site in the gene
84. Identification of a second mutation in the protein-coding sequence of the Z-type alpha-1-antitrypsin gene
85. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects
86. Population genetics of α1-antitrypsin in the Netherlands: description of a new electrophoretic variant
87. Classification of α1-antitrypsin (Pi) phenotypes of isoelectrofocusing: distinction of six sub-types of the PiM phenotype
88. Alpha-1-antitrypsin: further genetic heterogeneity revealed by isoelectric focusing
89. Distribution of α1-antitrypsin variants in a US white population
90. Pi M4: an additional Pi M sub-type
91. Pi (α1-antitrypsin) subtypes: frequency of PI*M4 in several populations
92. Alpha-1-antitrypsin: evidence for a fourth Pi M allele
93. Pi B, a new allele of α1-antitrypsin genetic variants
94. alhambra (Lys→Asp, Glu→Asp) with rapid anodal electrophoretic mobility
95. saskaloon
96. Techniques d'identification des groupes Pi
97. Genetics of the Pi system
98. New variants of α1-antitrypsin: comparison of Pi typing techniques
99. Three new rare variants of α1-antitrypsin
100. PI* (α1-antitrypsin) polymorphism in the Japanese: Confirmation of PI* M4 and description ol new Pi variants
101. cincinnati: a new alpha-1-antitrypsin allele in three Negro families
102. Distribution of α1-antitrypsin phenotypes in Japanese: description of Pi M subtypes by isoelectric focusing
103. cler variant
104. hou: two new alpha-1-antitrypsin alleles
105. α1-Antitrypsin polymorphism of a Bantu population: description of a new allele PiL
106. augsburg
107. Genetic typing of α1-antitrypsin by immunofixation electrophoresis
108. A new unstable Pi M variant of α-antitrypsin in a Finnish isolate
109. Inherited variants of α1-antitrypsin: a new allele Pi N
110. adelaide
111. hampton
112. Human alpha-1-antitrypsin genetic polymorphism: Pi N sub-types
113. Genetic variants of serum alpha-1-antitrypsin (Pi types) in Normans: common Pi M subtypes and new phenotypes
114. salnilouls: a new antitrypsin phenotype
115. okl: Isoelectric focusing with immobilized pH gradients as a tool for identification of Pi variants
116. clifton: a new α1-antitrypsin allele in an American Negro family
117. Geographical variability of alpha-1-antitrypsin alleles in China: a study on six Chinese populations
118. Pi T: A new allele in the alpha-1-antitrypsin system
119. The genetics of α1-antitrypsin: a family study in England and Scotland
120. finneytown: a new alpha-1-antitrypsin allele in an American Negro family
121. Hereditary variants of serum α1-antitrypsin
122. 5′ position does not affect inhibitory activity
123. pratt: a new alpha-1-antitrypsin allele in an American Negro family
124. Antitrypsin phenotype in St. Louis
125. Prevalence of alpha-1-antitrypsin Pi types among newborn infants of different ethnic backgrounds
126. Serum Pi types in some European, American, Asian and African populations
127. Alpha-1-antitrypsin (Pi) types in Korean and Chinese populations
128. Liver disease in alpha-1-antitrypsin deficiency detected by screening of 200,000 infants
129. The cellular defect in α1-proteinase inhibitor (α1-PI) deficiency expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA
130. Xenopus oocytes can synthesize but do not secrete the Z variant of human α1-antitrypsin
131. Translation and processing of normal (PiMM) and abnormal (PiZZ) human α1-antitrypsin
132. In vitro synthesis of M and Z forms of human α1-antitrypsin
133. Disruption of the Lys-290-Glu-342 salt bridge in human α1-antitrypsin does not prevent its synthesis and secretion
134. In vitro demonstration of the molecular basis of the secretory defect associated with expression of the Z α1-antitrypsin gene
135. α1-Antitrypsin: the presence of excess mannose in the Z variant isolated from liver
136. Characterization of the oligosaccharides of liver Z variant α1 -antitrypsin
137. Structural and functional characterization of the abnormal Z α1-antitrypsin isolated from human liver
138. Aggregation of plasma Z type α1-antitrypsin suggests basic defect for the deficiency
139. Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency
140. Population genetic studies of serum protein polymorphisms in four Spanish populations: part II
141. Genetic variants of serum α1-antitrypsin (Pi types) in Portuguese
142. 1 antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ: a survey of the British Thoracic Association
143. Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of α1-antitrypsin
144. Serum Pi types in patients with pulmonary diseases
145. α1-Antitrypsin S-types deficiency results from abnormal post-transcriptional processing
146. Alpha-1-antitrypsin: an ignored protein in understanding liver disease
147. Genetic polymorphism of serum alpha-1-protease inhibitor (alpha-1-antitrypsin): Pi I, a deficient allele of the Pi system
148. heerlen, a Pi M allele resulting in very low α1-antitrypsin serum levels
149. malton
150. duarte): inability to detect the heterozygous state by antitrypsin phenotyping
151. Alpha-1-antitrypsin deficiency with M-like phenotype
152. Does alpha-1-antitrypsin Pi null phenotype exist?
153. The Pi phenotype MP: Discovery of a ninth allele belonging to the system of inherited variants of serum α1-antitrypsin
154. α1-Antitrypsin deficiency a variant with no detectable α1-antitrypsin
155. Alpha-1-antitrypsin deficiency of PiOO type and connective tissue defect
156. Familial cases of α1-antitrypsin deficiency (Pi NULL Type)
157. Alpha-1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha-1-antitrypsin genes
158. Complete absence of serum alpha-1-antitrypsin in conjunction with an apparently normal gene structure
159. α1-Antitrypsin deficiency: Pi genotype ZO, SO, and MO
160. Intermediate alpha-1-antitrypsin deficiency: Pi M-
161. Intermediate alpha-1-antitrypsin deficiency resulting from a null gene (M-phenotype)
162. Further examples confirming the existence of Pi null (Pi-)
163. Mutation of antitrypsin to antithrombin: α1-antitrypsin Pittsburgh (358 Met→Arg), a fatal bleeding disorder
164. Alpha-1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XII
165. Kinetic studies on the interaction of α1-proteinase inhibitor (Pittsburgh) with trypsin-like serine proteinases
166. 358→Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment
167. Synthesis in E. coli of α1-antitrypsin variants of therapeutic potential for emphysema and thrombosis
168. Isolation and properties of recombinant DNA produced variants of human α1-proteinase inhibitor
169. Serpins: the superfamily of plasma serine proteinase inhibitors
170. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha-1-proteinase inhibitor
171. Cloning and sequence of cDNA coding for α1-antitrypsin
172. Sequence homology between human α1-antichymotrypsin, α1-antitrypsin and antithrombin III
173. Primary structure of antithrombin-III (heparin cofactor), partial homology between α1-antitrypsin and antithrombin III
174. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence
175. Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor
176. Characterization of a cDNA for human protein C inhibitor: a new member of the plasma serine protease inhibitor super-family
177. Reactive site peptide structural similarity between heparin cofactor I and antithrombin III
178. Primary structure of human α2-antiplasmin, a serine protease inhibitor (serpin)
179. Primary structure of the reactive site of human C1-inhibitor
180. Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions
181. The ovalbumin gene family: complete sequence and structure of the Y gene
182. Sequence homology and structural comparison between the chromosomal human α1-antitrypsin and chicken ovalbumin genes
183. Sequence homology between barley endosperm protein Z and protease inhibitors of the α1-antitrypsin family
184. DNA polymorphisms associated with alpha-1-antitrypsin and their clinical applications
185. Primate γ-globin DNA sequences and man's place among the great apes
186. Anti-elastases of the human alveolar structures: implications for the protease-antiprotease theory of emphysema
187. Experimental emphysema: its production with papain in normal and silicotic rats
188. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis
189. Cigarette smoking and lung destruction accumulation of neutrophils in the lungs of cigarette smokers
190. Oxidants, antioxidants and the pathogenesis of emphysema
191. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans
192. The oxidative inactivation of human alpha-1-proteinase inhibitor: further evidence of methionine at the reactive center
193. Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor
194. Kinetic and chemical evidence for the inability of oxidized alpha-1-proteinase inhibitor to protect lung elastin from elastolytic degradation
195. 1-antitrypsin deficiency
196. 1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z
197. Smoking, lung function, and α1-antitrypsin deficiency
198. α1-Antitrypsin deficiency in early childhood
199. Transport of protease across neonatal intestine and development of liver disease in infants with α1-antitrypsin deficiency
200. The ultrastructure of hepatocytes in alpha-1-antitrypsin deficiency with the genotype Pi—
201. Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency
202. Liver replacement for alpha-1-antitrypsin deficiency
203. Comparison of commercially available radial immunodiffusion kits for the determination of serum α1-antitrypsin concentrations
204. Methoden zur quantitativen Bestlmmung von Plasmaproteinen Durch Immunprazipitation
205. Isolation and properties, of human plasma α1-proteinase inhibitor
206. Monoclonal antibody specific for the mutant PiZ α1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers
207. Prenatal diagnosis of α1-antitrypsin deficiency and estimates of fetal risk for disease
208. Prenatal diagnosis of α1-antitrypsin deficiency by restriction fragment length polymorphisms, and comparison with oligonucleotide probe analysis
209. Diagnosis of alpha-1-antitrypsin deficiency with synthetic oligonucleotides
210. Possible applications of recombinant DNA technology to the diagnosis and study of variants of α1-antitrypsin